Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Medicine|November 21, 2020
A retrospective study of in-hospital mortality in patients with idiopathic pulmonary fibrosis between 2015 and 2018Michael T Durheim, Jennifer Judy, Shaun Bender, et al.
Lung|September 22, 2019
In-Hospital Mortality in Patients with Idiopathic Pulmonary Fibrosis: A US Cohort StudyMichael T Durheim, Jennifer Judy, Shaun Bender, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 5, 2021
Changes in Body Composition, Muscle Strength, and Fat Distribution Following Kidney TransplantationThomas Dienemann, Susan L Ziolkowski, Shaun Bender, et al.
Respiratory Research|January 8, 2022
Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO RegistryJoao A de Andrade, Tejaswini Kulkarni, Megan L Neely, et al.
JAMA Neurology|January 13, 2025
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label ExtensionDavid Adams, Jonas Wixner, Michael Polydefkis, et al.
Journal of the American College of Cardiology|August 6, 2025
Effects of Vutrisiran on Cardiac Function and Outcomes in Patients With Transthyretin Amyloidosis With CardiomyopathyKarola S Jering, Marianna Fontana, Hicham Skali, et al.
Nature Medicine|August 6, 2025
Effects of vutrisiran on cardiac structure and function in patients with transthyretin amyloidosis with cardiomyopathy: secondary outcomes of the HELIOS-B trialKarola S Jering, Marianna Fontana, Olivier Lairez, et al.
Chest|January 19, 2020
Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A Cross-Sectional Analysis of the IPF-PRO RegistryEmily C O'Brien, Anne S Hellkamp, Megan L Neely, et al.
Eclinicalmedicine|July 1, 2021
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trialGlenwood D Goss, Manuel Cobo, Shun Lu, et al.
Respiratory Research|May 31, 2019
Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO RegistryLaurie Snyder, Megan L Neely, Anne S Hellkamp, et al.
Pageof 4